New York · 86409

Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in New York

New York Medicare Avg
$103.22
10% above national avg
National Medicare Avg
$93.92
All states combined
Billed Charge (NY)
$210.59
What providers submit
Est. Commercial (NY)
$258.05
National avg: $210.38
Est. Cash / Self-Pay (NY)
$135.33
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

930
Services in NY
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New York

Provider Medicare Services
Empire City Laboratories, Inc $103.22 929

New York Pricing in Context

In New York, CPT code 86409 (Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)) carries an average Medicare payment of $103.22 — 10% above the national benchmark of $93.92. 2 providers across the state submitted claims for this procedure in 2023, performing 930 total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New York is $210.59, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in New York lands near $258.05, with self-pay cash prices typically around $135.33. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost in New York?

The average Medicare payment for Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in New York is $103.22, which is 10% above the national average of $93.92. Providers in NY typically bill $210.59 for this procedure.

What does Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cost with insurance in New York?

With commercial insurance in New York, Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs an estimated $258.05. Without insurance, the estimated cash price is $135.33. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in New York?

2 providers in New York billed Medicare for Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) in 2023, performing 930 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) cheaper in New York than the national average?

No — Measurement Of Neutralizing Antibody To Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) costs 10% above the national average in New York. The state average Medicare payment is $103.22 compared to $93.92 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial